

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | notochord development (GO:0030903) | 8.03416294 |
| 2 | peristalsis (GO:0030432) | 6.19199586 |
| 3 | regulation of somitogenesis (GO:0014807) | 5.95231030 |
| 4 | vitamin transmembrane transport (GO:0035461) | 5.42168390 |
| 5 | regulation of gene silencing by RNA (GO:0060966) | 5.20493886 |
| 6 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.20493886 |
| 7 | regulation of gene silencing by miRNA (GO:0060964) | 5.20493886 |
| 8 | urinary tract smooth muscle contraction (GO:0014848) | 5.00435751 |
| 9 | import into cell (GO:0098657) | 4.86736084 |
| 10 | inner cell mass cell proliferation (GO:0001833) | 4.79435643 |
| 11 | flavonoid metabolic process (GO:0009812) | 4.40659105 |
| 12 | iron ion import (GO:0097286) | 4.38052299 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.22986075 |
| 14 | regulation of establishment of cell polarity (GO:2000114) | 4.18210097 |
| 15 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 4.14012514 |
| 16 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.13672921 |
| 17 | dorsal/ventral axis specification (GO:0009950) | 4.05596292 |
| 18 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.04319253 |
| 19 | sulfation (GO:0051923) | 3.96079015 |
| 20 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.93551427 |
| 21 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.92873711 |
| 22 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.92061320 |
| 23 | regulation of chromatin binding (GO:0035561) | 3.87170164 |
| 24 | regulation of hippo signaling (GO:0035330) | 3.83211245 |
| 25 | neurotransmitter catabolic process (GO:0042135) | 3.72644062 |
| 26 | inner ear receptor cell development (GO:0060119) | 3.67766619 |
| 27 | endocardial cushion development (GO:0003197) | 3.63106852 |
| 28 | alanine transport (GO:0032328) | 3.60822160 |
| 29 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.59989157 |
| 30 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.57264941 |
| 31 | intestinal cholesterol absorption (GO:0030299) | 3.50822431 |
| 32 | post-embryonic morphogenesis (GO:0009886) | 3.50723685 |
| 33 | regulation of DNA endoreduplication (GO:0032875) | 3.43844358 |
| 34 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.40796468 |
| 35 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.40457267 |
| 36 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.40457267 |
| 37 | nuclear pore complex assembly (GO:0051292) | 3.37055105 |
| 38 | L-amino acid import (GO:0043092) | 3.35506895 |
| 39 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.33577587 |
| 40 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.27923843 |
| 41 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.23782321 |
| 42 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.23782321 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.21659686 |
| 44 | negative regulation of sodium ion transport (GO:0010766) | 3.17380499 |
| 45 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 3.13634835 |
| 46 | protein targeting to vacuole (GO:0006623) | 3.12769808 |
| 47 | protein targeting to lysosome (GO:0006622) | 3.12769808 |
| 48 | establishment of protein localization to vacuole (GO:0072666) | 3.12769808 |
| 49 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.12206588 |
| 50 | mannose metabolic process (GO:0006013) | 3.11917229 |
| 51 | biotin metabolic process (GO:0006768) | 3.11307428 |
| 52 | phasic smooth muscle contraction (GO:0014821) | 3.09329487 |
| 53 | cellular response to ethanol (GO:0071361) | 3.07224388 |
| 54 | maintenance of protein location in nucleus (GO:0051457) | 3.07190002 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.04747997 |
| 56 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.03793064 |
| 57 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.01682473 |
| 58 | positive regulation of fatty acid oxidation (GO:0046321) | 2.99428232 |
| 59 | coenzyme A biosynthetic process (GO:0015937) | 2.98750113 |
| 60 | proline biosynthetic process (GO:0006561) | 2.98140704 |
| 61 | nuclear pore organization (GO:0006999) | 2.96359046 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 2.95407292 |
| 63 | multicellular organismal movement (GO:0050879) | 2.95104390 |
| 64 | musculoskeletal movement (GO:0050881) | 2.95104390 |
| 65 | regulation of protein activation cascade (GO:2000257) | 2.95030775 |
| 66 | regulation of complement activation (GO:0030449) | 2.94357957 |
| 67 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.93787822 |
| 68 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.93787822 |
| 69 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.93787822 |
| 70 | macroautophagy (GO:0016236) | 2.93430047 |
| 71 | snRNA metabolic process (GO:0016073) | 2.93134899 |
| 72 | regulation of cell cycle G2/M phase transition (GO:1902749) | 2.92971395 |
| 73 | negative regulation of macroautophagy (GO:0016242) | 2.87896012 |
| 74 | kynurenine metabolic process (GO:0070189) | 2.86573558 |
| 75 | lytic vacuole organization (GO:0080171) | 2.86547097 |
| 76 | lysosome organization (GO:0007040) | 2.86547097 |
| 77 | regulation of fatty acid oxidation (GO:0046320) | 2.84963678 |
| 78 | nephron epithelium morphogenesis (GO:0072088) | 2.81305667 |
| 79 | nephron tubule morphogenesis (GO:0072078) | 2.81305667 |
| 80 | regulation of apoptotic cell clearance (GO:2000425) | 2.81047955 |
| 81 | snRNA processing (GO:0016180) | 2.77921896 |
| 82 | receptor catabolic process (GO:0032801) | 2.72631324 |
| 83 | COPII vesicle coating (GO:0048208) | 2.69050588 |
| 84 | amino acid import (GO:0043090) | 2.68478812 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.68472208 |
| 86 | serine family amino acid catabolic process (GO:0009071) | 2.67569495 |
| 87 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.66914965 |
| 88 | histone-serine phosphorylation (GO:0035404) | 2.66114936 |
| 89 | synapsis (GO:0007129) | 2.65922048 |
| 90 | regulation of cholesterol metabolic process (GO:0090181) | 2.64609789 |
| 91 | labyrinthine layer development (GO:0060711) | 2.63617859 |
| 92 | tyrosine metabolic process (GO:0006570) | 2.63048053 |
| 93 | phenol-containing compound catabolic process (GO:0019336) | 2.62594327 |
| 94 | regulation of translational fidelity (GO:0006450) | 2.62153122 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 2.61759530 |
| 96 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.61206935 |
| 97 | response to UV-C (GO:0010225) | 2.61166736 |
| 98 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.59466779 |
| 99 | regulation of DNA damage checkpoint (GO:2000001) | 2.59222271 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 2.58159632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.77206944 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.31373214 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.84696647 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.31713253 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.09942658 |
| 6 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.83345857 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.61214662 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53822658 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.45069450 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.44684623 |
| 11 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.44145485 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.29937960 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.29104660 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.27591851 |
| 15 | KDM5A_27292631_Chip-Seq_BREAST_Human | 2.16105207 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15122799 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12809419 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09213744 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08776835 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02110026 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.01930664 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94700797 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.93066160 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.91734567 |
| 25 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.82941513 |
| 26 | GATA1_19941826_ChIP-Seq_K562_Human | 1.81475102 |
| 27 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.79958845 |
| 28 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.77050880 |
| 29 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.75127361 |
| 30 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.71653088 |
| 31 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.67560295 |
| 32 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.58366336 |
| 33 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.57691323 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56226655 |
| 35 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.52707677 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.50583493 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.49854965 |
| 38 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.45480171 |
| 39 | GATA2_19941826_ChIP-Seq_K562_Human | 1.44823461 |
| 40 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.39124572 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38349606 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37795217 |
| 43 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.37460015 |
| 44 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.32410707 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32126884 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30125602 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.29974742 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29550980 |
| 49 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23461610 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23244936 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22814055 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21387395 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21184642 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20230526 |
| 55 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20048655 |
| 56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19172744 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19039722 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18727383 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17849246 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.17180746 |
| 61 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15638772 |
| 62 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.14030337 |
| 63 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13128426 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12612477 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11166630 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10750937 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10354190 |
| 68 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10092656 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.08319680 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06511182 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04892262 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04688875 |
| 73 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.04404815 |
| 74 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.04113138 |
| 75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03273894 |
| 76 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02825540 |
| 77 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02791171 |
| 78 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00755034 |
| 79 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.99738928 |
| 80 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99425943 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.98461478 |
| 82 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97930009 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96086190 |
| 84 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95081556 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94908123 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.94525869 |
| 87 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.93372663 |
| 88 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91372231 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90117427 |
| 90 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.90109847 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89430115 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88606093 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88242412 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.87692939 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87367878 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86587063 |
| 97 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86384437 |
| 98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85858957 |
| 99 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.84356313 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.82850322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.29744890 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88937007 |
| 3 | MP0002163_abnormal_gland_morphology | 2.83070239 |
| 4 | MP0005171_absent_coat_pigmentation | 2.76652225 |
| 5 | MP0005360_urolithiasis | 2.58354397 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.57365424 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.55183043 |
| 8 | MP0004134_abnormal_chest_morphology | 2.52347704 |
| 9 | MP0004130_abnormal_muscle_cell | 2.48944845 |
| 10 | MP0001661_extended_life_span | 2.31204279 |
| 11 | MP0003959_abnormal_lean_body | 2.30306551 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.30062606 |
| 13 | MP0005451_abnormal_body_composition | 2.26856496 |
| 14 | MP0005408_hypopigmentation | 2.25094329 |
| 15 | MP0003195_calcinosis | 2.23311125 |
| 16 | MP0004233_abnormal_muscle_weight | 2.18408616 |
| 17 | MP0002102_abnormal_ear_morphology | 2.14272224 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.08332766 |
| 19 | MP0002089_abnormal_postnatal_growth/wei | 2.04300114 |
| 20 | MP0003136_yellow_coat_color | 2.02571198 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.94135491 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 1.90444405 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.83399730 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.82786419 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.82049070 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.77642228 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.66747373 |
| 28 | MP0004043_abnormal_pH_regulation | 1.65962888 |
| 29 | MP0005365_abnormal_bile_salt | 1.65305937 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.60244227 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.54840199 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.53552257 |
| 33 | MP0003123_paternal_imprinting | 1.45878263 |
| 34 | MP0002160_abnormal_reproductive_system | 1.45494152 |
| 35 | MP0004858_abnormal_nervous_system | 1.44887716 |
| 36 | MP0000371_diluted_coat_color | 1.42926285 |
| 37 | MP0000733_abnormal_muscle_development | 1.42884761 |
| 38 | MP0001324_abnormal_eye_pigmentation | 1.42183480 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.37924334 |
| 40 | MP0005332_abnormal_amino_acid | 1.37364629 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.36646978 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.36403681 |
| 43 | MP0005647_abnormal_sex_gland | 1.35879797 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.23899678 |
| 45 | MP0002932_abnormal_joint_morphology | 1.21037115 |
| 46 | MP0009115_abnormal_fat_cell | 1.19338379 |
| 47 | MP0002111_abnormal_tail_morphology | 1.16597989 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.16120808 |
| 49 | MP0002269_muscular_atrophy | 1.14683449 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.14067863 |
| 51 | MP0000613_abnormal_salivary_gland | 1.13129253 |
| 52 | MP0005448_abnormal_energy_balance | 1.13128061 |
| 53 | MP0000609_abnormal_liver_physiology | 1.08701599 |
| 54 | MP0002075_abnormal_coat/hair_pigmentati | 1.08131115 |
| 55 | MP0003632_abnormal_nervous_system | 1.05982627 |
| 56 | MP0005334_abnormal_fat_pad | 1.04324473 |
| 57 | MP0005266_abnormal_metabolism | 1.04234915 |
| 58 | MP0008057_abnormal_DNA_replication | 1.02673030 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.02556937 |
| 60 | MP0005670_abnormal_white_adipose | 1.01285009 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.98039796 |
| 62 | MP0003252_abnormal_bile_duct | 0.97624368 |
| 63 | MP0006138_congestive_heart_failure | 0.97492446 |
| 64 | MP0003011_delayed_dark_adaptation | 0.95120903 |
| 65 | MP0003890_abnormal_embryonic-extraembry | 0.92569542 |
| 66 | MP0005666_abnormal_adipose_tissue | 0.91058641 |
| 67 | MP0004147_increased_porphyrin_level | 0.89858638 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 0.88421093 |
| 69 | MP0005410_abnormal_fertilization | 0.87933410 |
| 70 | MP0000747_muscle_weakness | 0.87697296 |
| 71 | MP0002971_abnormal_brown_adipose | 0.86594465 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.86246486 |
| 73 | MP0009840_abnormal_foam_cell | 0.85585312 |
| 74 | MP0002009_preneoplasia | 0.85394367 |
| 75 | MP0003868_abnormal_feces_composition | 0.84293314 |
| 76 | MP0000750_abnormal_muscle_regeneration | 0.84111788 |
| 77 | MP0008770_decreased_survivor_rate | 0.83725668 |
| 78 | MP0001873_stomach_inflammation | 0.82940886 |
| 79 | MP0001145_abnormal_male_reproductive | 0.79790176 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.78729579 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 0.77784123 |
| 82 | MP0005195_abnormal_posterior_eye | 0.77258599 |
| 83 | MP0001186_pigmentation_phenotype | 0.76055727 |
| 84 | MP0009697_abnormal_copulation | 0.75324710 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 0.73941251 |
| 86 | MP0004957_abnormal_blastocyst_morpholog | 0.73807053 |
| 87 | MP0000372_irregular_coat_pigmentation | 0.72371971 |
| 88 | MP0003942_abnormal_urinary_system | 0.71487252 |
| 89 | MP0003936_abnormal_reproductive_system | 0.71025181 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.70840221 |
| 91 | MP0003698_abnormal_male_reproductive | 0.70527122 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.70003740 |
| 93 | MP0002085_abnormal_embryonic_tissue | 0.67694175 |
| 94 | MP0004272_abnormal_basement_membrane | 0.67099349 |
| 95 | MP0005083_abnormal_biliary_tract | 0.66495275 |
| 96 | MP0003699_abnormal_female_reproductive | 0.64921659 |
| 97 | MP0003646_muscle_fatigue | 0.64307250 |
| 98 | MP0001544_abnormal_cardiovascular_syste | 0.64184710 |
| 99 | MP0005385_cardiovascular_system_phenoty | 0.64184710 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.64031804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.60712336 |
| 2 | Flat acetabular roof (HP:0003180) | 5.47535625 |
| 3 | J-shaped sella turcica (HP:0002680) | 5.12177832 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.96944329 |
| 5 | Genetic anticipation (HP:0003743) | 4.48388782 |
| 6 | Clumsiness (HP:0002312) | 4.38314143 |
| 7 | Dysmetric saccades (HP:0000641) | 4.32179404 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.17165472 |
| 9 | Diastasis recti (HP:0001540) | 4.14075213 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.75715230 |
| 11 | Abnormality of the odontoid process (HP:0003310) | 3.71243504 |
| 12 | Tinnitus (HP:0000360) | 3.66585027 |
| 13 | Deformed sella turcica (HP:0002681) | 3.59212406 |
| 14 | Flared iliac wings (HP:0002869) | 3.58927189 |
| 15 | Abnormality of the lumbar spine (HP:0100712) | 3.24160169 |
| 16 | Abnormality of the sella turcica (HP:0002679) | 3.21141341 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.12170068 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.08931045 |
| 19 | Broad alveolar ridges (HP:0000187) | 3.08744666 |
| 20 | Spontaneous abortion (HP:0005268) | 2.82993802 |
| 21 | Hypoplasia of the odontoid process (HP:0003311) | 2.82304657 |
| 22 | Bowel incontinence (HP:0002607) | 2.76511702 |
| 23 | Concave nail (HP:0001598) | 2.67865858 |
| 24 | Thoracic kyphosis (HP:0002942) | 2.63514889 |
| 25 | Vertebral arch anomaly (HP:0008438) | 2.62217551 |
| 26 | Abnormality of the wing of the ilium (HP:0011867) | 2.50655244 |
| 27 | Abnormal large intestine physiology (HP:0012700) | 2.49078406 |
| 28 | Abnormality of the thoracic spine (HP:0100711) | 2.48553450 |
| 29 | Ovoid vertebral bodies (HP:0003300) | 2.45448151 |
| 30 | Urethral obstruction (HP:0000796) | 2.45191452 |
| 31 | Persistence of primary teeth (HP:0006335) | 2.43691379 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.41552526 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.41552526 |
| 34 | Carpal bone hypoplasia (HP:0001498) | 2.39828550 |
| 35 | Confusion (HP:0001289) | 2.37908426 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.37357234 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 2.37272580 |
| 38 | Protruding tongue (HP:0010808) | 2.36381409 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.35916521 |
| 40 | Azoospermia (HP:0000027) | 2.34078483 |
| 41 | Pseudobulbar signs (HP:0002200) | 2.32665151 |
| 42 | Thoracolumbar scoliosis (HP:0002944) | 2.32189961 |
| 43 | Hydroxyprolinuria (HP:0003080) | 2.29435188 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 2.29435188 |
| 45 | Acanthocytosis (HP:0001927) | 2.28065835 |
| 46 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.27322451 |
| 47 | Beaking of vertebral bodies (HP:0004568) | 2.26396649 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.26196249 |
| 49 | Progressive cerebellar ataxia (HP:0002073) | 2.23900870 |
| 50 | Protuberant abdomen (HP:0001538) | 2.20201322 |
| 51 | Hypoplastic pelvis (HP:0008839) | 2.19473636 |
| 52 | Anomalous pulmonary venous return (HP:0010772) | 2.14748754 |
| 53 | Progressive external ophthalmoplegia (HP:0000590) | 2.12635619 |
| 54 | Cystic liver disease (HP:0006706) | 2.10776185 |
| 55 | Macroorchidism (HP:0000053) | 2.10461601 |
| 56 | Aortic regurgitation (HP:0001659) | 2.07784384 |
| 57 | Abnormality of the acetabulum (HP:0003170) | 2.07412807 |
| 58 | Tented upper lip vermilion (HP:0010804) | 2.05371369 |
| 59 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04694126 |
| 60 | Macroglossia (HP:0000158) | 2.04290166 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02285109 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02285109 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02285109 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.00286735 |
| 65 | Neonatal hypoglycemia (HP:0001998) | 1.99788967 |
| 66 | Blue irides (HP:0000635) | 1.98870636 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96378502 |
| 68 | Hypolipoproteinemia (HP:0010981) | 1.95093969 |
| 69 | Large for gestational age (HP:0001520) | 1.92968393 |
| 70 | Dysostosis multiplex (HP:0000943) | 1.91517158 |
| 71 | Self-mutilation (HP:0000742) | 1.91075706 |
| 72 | Homocystinuria (HP:0002156) | 1.90711848 |
| 73 | Abnormality of homocysteine metabolism (HP:0010919) | 1.90711848 |
| 74 | Short chin (HP:0000331) | 1.90440330 |
| 75 | True hermaphroditism (HP:0010459) | 1.88236786 |
| 76 | Sparse lateral eyebrow (HP:0005338) | 1.87283068 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86185861 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86185861 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86185861 |
| 80 | Pancreatic cysts (HP:0001737) | 1.85985651 |
| 81 | Furrowed tongue (HP:0000221) | 1.80760701 |
| 82 | Pathologic fracture (HP:0002756) | 1.78340664 |
| 83 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.76882504 |
| 84 | Abnormality of the common coagulation pathway (HP:0010990) | 1.75086298 |
| 85 | Congenital stationary night blindness (HP:0007642) | 1.74802411 |
| 86 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.74748658 |
| 87 | Heterotopia (HP:0002282) | 1.73869607 |
| 88 | Postural tremor (HP:0002174) | 1.73232368 |
| 89 | Abnormality of the pulmonary veins (HP:0011718) | 1.72144432 |
| 90 | External ophthalmoplegia (HP:0000544) | 1.71916013 |
| 91 | Hyperglycinuria (HP:0003108) | 1.71265731 |
| 92 | Slow saccadic eye movements (HP:0000514) | 1.70228746 |
| 93 | Prominent occiput (HP:0000269) | 1.69462324 |
| 94 | Smooth philtrum (HP:0000319) | 1.69384798 |
| 95 | Hypopigmentation of the fundus (HP:0007894) | 1.65633469 |
| 96 | Reticulocytosis (HP:0001923) | 1.65627591 |
| 97 | Hypoplastic scapulae (HP:0000882) | 1.65615638 |
| 98 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.65615638 |
| 99 | Hemiplegia (HP:0002301) | 1.64261370 |
| 100 | Broad palm (HP:0001169) | 1.63165619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 6.34974422 |
| 2 | ADRBK2 | 4.36327639 |
| 3 | WNK4 | 3.80129425 |
| 4 | GRK1 | 3.45240767 |
| 5 | TESK2 | 3.44106458 |
| 6 | CDK12 | 3.12996445 |
| 7 | EEF2K | 2.99394208 |
| 8 | ICK | 2.74178676 |
| 9 | BRSK2 | 2.72401837 |
| 10 | NEK2 | 2.71080337 |
| 11 | AKT3 | 2.56674705 |
| 12 | BLK | 2.18542490 |
| 13 | FGFR4 | 2.06106680 |
| 14 | MAPKAPK3 | 2.03138013 |
| 15 | CLK1 | 1.94732791 |
| 16 | PRKD3 | 1.62543920 |
| 17 | PDGFRA | 1.52828404 |
| 18 | EIF2AK1 | 1.51970774 |
| 19 | FRK | 1.40443069 |
| 20 | WNK1 | 1.40437611 |
| 21 | FLT3 | 1.31290474 |
| 22 | MTOR | 1.29072665 |
| 23 | RIPK1 | 1.27086081 |
| 24 | PKN2 | 1.26080778 |
| 25 | CAMKK2 | 1.23189446 |
| 26 | SIK1 | 1.19593339 |
| 27 | SIK2 | 1.18749199 |
| 28 | NME1 | 1.13443399 |
| 29 | NEK9 | 1.12456651 |
| 30 | PDPK1 | 1.08823797 |
| 31 | FGFR3 | 1.08356239 |
| 32 | MAP3K13 | 1.04089891 |
| 33 | TRPM7 | 0.97494979 |
| 34 | MAPK11 | 0.97443166 |
| 35 | PRKAA2 | 0.94748239 |
| 36 | NTRK1 | 0.94228197 |
| 37 | RIPK4 | 0.93288288 |
| 38 | RPS6KB2 | 0.91917830 |
| 39 | ACVR1B | 0.91219687 |
| 40 | RET | 0.89865250 |
| 41 | BRSK1 | 0.88162498 |
| 42 | CDK7 | 0.87387033 |
| 43 | CAMKK1 | 0.85191288 |
| 44 | TTN | 0.85095060 |
| 45 | STK3 | 0.84801604 |
| 46 | PIK3CA | 0.84289310 |
| 47 | PTK6 | 0.83361492 |
| 48 | RPS6KB1 | 0.82242094 |
| 49 | PDK1 | 0.76480676 |
| 50 | INSRR | 0.75770735 |
| 51 | LATS1 | 0.74616168 |
| 52 | CAMK1D | 0.73681423 |
| 53 | MAP3K2 | 0.72502039 |
| 54 | MET | 0.71093414 |
| 55 | ADRBK1 | 0.63447332 |
| 56 | KSR2 | 0.57455808 |
| 57 | PRKD2 | 0.56884980 |
| 58 | CHEK1 | 0.56597399 |
| 59 | PRKAA1 | 0.55932632 |
| 60 | CHEK2 | 0.53864953 |
| 61 | PTK2 | 0.52053255 |
| 62 | ATR | 0.51346344 |
| 63 | MAPKAPK5 | 0.50633993 |
| 64 | YES1 | 0.49997087 |
| 65 | TLK1 | 0.49236350 |
| 66 | MAP3K9 | 0.48625998 |
| 67 | MAP3K7 | 0.47353109 |
| 68 | CDK1 | 0.45268201 |
| 69 | TYRO3 | 0.45081723 |
| 70 | NEK6 | 0.44708443 |
| 71 | BMX | 0.43973104 |
| 72 | BRD4 | 0.43429205 |
| 73 | PAK2 | 0.43148959 |
| 74 | MAP2K4 | 0.42593609 |
| 75 | CDK2 | 0.41568467 |
| 76 | ERBB4 | 0.38088856 |
| 77 | AURKB | 0.37881969 |
| 78 | ERBB2 | 0.37707195 |
| 79 | FGFR1 | 0.37395261 |
| 80 | WEE1 | 0.37064289 |
| 81 | IRAK3 | 0.37056365 |
| 82 | HIPK2 | 0.36210553 |
| 83 | TTK | 0.36172747 |
| 84 | PDGFRB | 0.35933430 |
| 85 | EPHA2 | 0.35748498 |
| 86 | PTK2B | 0.35253994 |
| 87 | CDC42BPA | 0.33447653 |
| 88 | EPHA3 | 0.33103066 |
| 89 | CCNB1 | 0.32475238 |
| 90 | MAP2K1 | 0.31855703 |
| 91 | SGK1 | 0.28733257 |
| 92 | MAP2K6 | 0.28268623 |
| 93 | FER | 0.28078824 |
| 94 | PRKCH | 0.27522706 |
| 95 | MAPK10 | 0.27023959 |
| 96 | MAPK14 | 0.25724227 |
| 97 | CDK4 | 0.25019769 |
| 98 | CDK9 | 0.23726234 |
| 99 | ATM | 0.22522569 |
| 100 | SYK | 0.22371034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.13401560 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.72247976 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.53104486 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47356386 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.34560063 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.03446509 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99751561 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91882280 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.88554767 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84994371 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77986132 |
| 12 | ABC transporters_Homo sapiens_hsa02010 | 1.72041925 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.65394562 |
| 14 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58567447 |
| 15 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.52255049 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.52205838 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.50930654 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50862511 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43619745 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42981875 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.41130163 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40670844 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38262254 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33033720 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.31396666 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.24090180 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23275039 |
| 28 | Melanoma_Homo sapiens_hsa05218 | 1.18734980 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.17430233 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17362848 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16426266 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14110406 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13826398 |
| 34 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13017148 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.08310884 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.06812281 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06670271 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.04775935 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.03550823 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01823504 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98994989 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98823723 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97027061 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95321330 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93135997 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87980808 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87235427 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87108287 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85941933 |
| 50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84167696 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81995544 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80633054 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77750566 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76855868 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.74984540 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72989278 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72565119 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72484234 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71921410 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71334979 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70992687 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70898020 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.70322554 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70071647 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.69430236 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69399654 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69286932 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68822766 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67842008 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67576403 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.65296695 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64730416 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.64633168 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62468051 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61741382 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61584415 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58218526 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56709227 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54844707 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54506024 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50836346 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49435131 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49340113 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49018734 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48633140 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.47924436 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47903191 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45005989 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44597593 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43781898 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43468444 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43426797 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41903030 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38909263 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38296235 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38202846 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37832865 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36758097 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34735203 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34497977 |

